New York, NY -- (SBWIRE) -- 01/29/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: iShares MSCI Taiwan Index (ETF) (NYSEARCA:EWT), Hemispherx BioPharma, Inc (NYSEMKT:HEB), MFA Financial, Inc (NYSE:MFA), E Commerce China Dangdang Inc (ADR) (NYSE:DANG)
iShares MSCI Taiwan Index (ETF) (NYSEARCA:EWT) the stock opened the session at $13.66but then moved to $13.72. At that price, the stock showed a positive performance of 13.72%. Ishares MSCI Taiwan Index Fund, formerly iShares MSCI Taiwan ETF, (the Fund), is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Taiwan IndexSM (the Index).
Will EWT Continue To Move Higher? Find Out Here
Hemispherx BioPharma, Inc (NYSEMKT:HEB) opened the session at $0.46 and closed the session at $0.500. The stock showed a positive performance of 4.36% in previous trading session. Traded with volume of 2.89 million shares in the prior session and the average volume of the stock remained 4.56 million shares. Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
For How Long HEB will fight for Profitability? Read This Trend Analysis report
MFA Financial, Inc (NYSE:MFA) opened the session at $7.20 and closed the session at $7.24. The stock showed a positive performance of 0.98% in previous trading session. Traded with volume of 2.88 million shares in the prior session and the average volume of the stock remained 3.52 million shares. The beta of the stock remained 0.33. MFA Financial, Inc., is engaged in the business of investing, on a leveraged basis, in residential Agency mortgage-backed securities (MBS) and Non-Agency MBS. Its business objective is to generate net income for distribution to its stockholders resulting from the difference between the interest and other income it earn on its investments and the interest expense it pays on the borrowings,
Why Should Investors Buy MFA After The Recent Gain? Just Go Here and Find Out
E Commerce China Dangdang Inc (ADR) (NYSE:DANG) the stock advanced 8.71% and finished the session at $9.61. Traded with volume of 2.89 million shares in the prior session and the average volume of the stock remained 2.34 million shares. The beta of the stock remained 4.88. E-Commerce China Dangdang Inc. (Dangdang) is a holding company. It is a business-to-consumer (B2C), e-commerce Company in the People’s Republic of China. As of September 30, 2010, it offered approximately 590,000 book titles on its Website, including more than 570,000 Chinese language titles.
Will DANG Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)